Background. The progression of tumor growth requires the recruitment of new blood vessels. It has been suggested that the degree of neovascularization would correlate with clinical prognosis. The purpose of the present study was to ascertain whether tumor vascularization correlated with clinical out
Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice
β Scribed by J. J. Quak; A. J. M. Balm; J. G. P. Brakkee; R. J. Scheper; H. J. Haisma; B. J. M. Braakhuis; C. J. L. M. Meijer; G. B. Snow
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- French
- Weight
- 693 KB
- Volume
- 44
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Nude mice carrying human squamous-cell carcinoma xenografts were given i.v. injections of radiolabelled monoclonal antibodies (Mas). MAb E 48, which reacts with squamouscell carcinomas, was labelled with i3'l, while a second control MAb of similar immunoglobulin subclass was labelled with lZ5l. Both antibodies were injected simultaneously, then the mice were scanned with a gamma camera or their tissues were removed uptake was calculated as a percentage of the Uptake of E 48 reached a peak value of I6%/g e uptake of the control antibody was less than 1.8%/g. By 24 hr after injection tumor could be visualized without subtraction techniques. At days 3 and 7, isible on imaging. These findings sugle of high specificity in targeting isocarcinomas in an experimental setting.
π SIMILAR VOLUMES
## BACKGROUND. The immunoglobulin G 1 (IgG 1 ) monoclonal
Biopsy specimens from 62 human single primary squamous cell carcinomas (SCC) of the head and neck were xenografted into nude mice. To evaluate the prognostic significance of successful heterotransplantation, the 62 cases were retrospectively examined for survival, adjusting for possible confounders
## Abstract ## Background. Induction chemotherapy may contribute to decreased local and distant recurrences in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) resectable for cure. ## Methods. Patients with previously untreated locally advanced stage IIIβIV (N0